Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR

Anieta Sieuwerts, Jaco Kraan, Joan Vries, Petra Spoel, Bianca Mostert, John Martens, Jan willem Gratama, Stefan Sleijfer, John Foekens

Research output: Contribution to journalArticleAcademicpeer-review

155 Citations (Scopus)


Detection of circulating tumor cells (CTCs) in whole blood from metastatic cancer patients by the Cell-Search (TM) CTC Test (Veridex LLC, Warren, NJ, USA) has been shown to have clinical relevance. In addition to enumeration, there is great interest in molecular characterization of these CTCs. We aimed to establish a robust method to perform mRNA expression analysis of multiple genes by a real-time reverse transcriptase (RT)-PCR on small numbers of CTCs enriched from whole blood by the CellSearch (TM) system. Despite the 4 log depletion of leukocytes after CellSearch enrichment, the CTC-enriched fractions still contained leukocytes, in particular B-lymphocytes, which severely interfered with our CTC-specific gene expression profiling. After extensive washing and leukocyte-specific depletion by anti-CD45 coated magnetic beads prior to CellSearch TM enrichment, the number of leukocytes present in the enriched fraction was still high (range 60-929). However, by using a set of genes with no or minor expression by leukocytes, we succeeded to perform quantitative gene expression profiling specific for as little as one breast cancer CTC present in a CTC-enriched environment typically containing over 800 contaminating leukocytes. Our method allows molecular characterization specific for as little as one CTC, and can be used to expand the understanding of the biology of metastasis and, potentially, to improve patient management.
Original languageUndefined/Unknown
Pages (from-to)455-468
Number of pages14
JournalBreast Cancer Research and Treatment
Issue number3
Publication statusPublished - 2009

Cite this